Healthcare Sector
Major Pharmaceutical Preparations Industry
|
|
|
Data by Company within Major Pharmaceutical Preparations Industry
|
|
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
Company |
(Millions) |
(Millions) |
(Millions) |
Number |
Abeona Therapeutics Inc. |
$ 954 |
$ 1 |
$ -27 |
- |
Abbott Laboratories |
$ 104,042 |
$ 27,390 |
$ 477 |
77,000 |
Arbutus Biopharma Corp |
$ 300 |
$ 11 |
$ -84 |
- |
Acadia Pharmaceuticals Inc |
$ 2,470 |
$ 125 |
$ -289 |
- |
Achillion Pharmaceuticals Inc |
$ 503 |
- |
$ -69 |
- |
Acelrx Pharmaceuticals Inc |
$ 119 |
$ 8 |
$ -52 |
- |
Acura Pharmaceuticals, Inc |
$ 9 |
$ 7 |
$ -2 |
- |
Alcobra Ltd. |
- |
- |
$ 0 |
- |
Adamis Pharmaceuticals Corp |
$ 131 |
$ 13 |
$ -26 |
- |
Adamas Pharmaceuticals Inc |
$ 648 |
- |
$ -89 |
- |
Aduro Biotech, Inc. |
$ 1,030 |
$ 17 |
$ -92 |
- |
Advaxis, Inc. |
$ 68 |
$ 10 |
$ -97 |
- |
Aegerion Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
Agios Pharmaceuticals Inc |
$ 4,224 |
$ 43 |
$ -315 |
- |
Aeglea Biotherapeutics, Inc. |
$ 131 |
$ 5 |
$ -27 |
- |
Agile Therapeutics Inc |
$ 94 |
- |
$ -28 |
- |
Aimmune Therapeutics, Inc. |
$ 1,608 |
- |
$ -131 |
- |
Achaogen Inc |
$ 569 |
$ 11 |
$ -126 |
- |
Akebia Therapeutics, Inc. |
$ 441 |
$ 178 |
$ -77 |
- |
Akorn Inc |
$ 2,464 |
$ 841 |
$ -25 |
- |
Albireo Pharma, Inc. |
$ 297 |
- |
$ -24 |
- |
Aldeyra Therapeutics, Inc. |
$ 134 |
- |
$ -22 |
- |
Alimera Sciences Inc |
$ 77 |
$ 36 |
$ -22 |
- |
Alkermes Plc. |
$ 7,082 |
$ 903 |
$ -158 |
- |
Alnylam Pharmaceuticals, Inc. |
$ 9,616 |
$ 94 |
$ -500 |
- |
Alexza Pharmaceuticals Inc. |
- |
- |
$ 0 |
- |
Alexion Pharmaceuticals Inc |
$ 24,315 |
$ 3,551 |
$ 443 |
2,273 |
Amag Pharmaceuticals Inc. |
$ 673 |
$ 610 |
$ -199 |
- |
Amylin Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
Ampio Pharmaceuticals, Inc. |
$ 237 |
- |
$ -52 |
- |
Amphastar Pharmaceuticals, Inc. |
$ 951 |
$ 240 |
$ -2 |
- |
Amarin Corp Plcuk |
$ 796 |
$ 181 |
$ -68 |
- |
Anacor Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
Ani Pharmaceuticals Inc |
$ 693 |
$ 177 |
$ -1 |
- |
Antriabio, Inc. |
$ 43 |
- |
$ -27 |
- |
Anthera Pharmaceuticals Inc |
$ 4 |
- |
$ -27 |
- |
Apricus Biosciences, Inc. |
$ 4 |
- |
$ 0 |
- |
Aquinox Pharmaceuticals, Inc |
$ 295 |
- |
$ -50 |
- |
Ardelyx, Inc. |
$ 231 |
- |
$ -64 |
- |
Argos Therapeutics Inc |
$ 12 |
$ 2 |
$ -44 |
- |
Aralez Pharmaceuticals Inc. |
$ 93 |
$ 106 |
$ -125 |
- |
Arena Pharmaceuticals Inc |
$ 1,200 |
$ 21 |
$ -93 |
- |
Arqule Inc |
$ 245 |
- |
$ -29 |
- |
Array Biopharma Inc |
$ 2,816 |
$ 139 |
$ -137 |
- |
Athersys, Inc |
$ 296 |
$ 4 |
$ 0 |
- |
Actinium Pharmaceuticals, Inc. |
$ 30 |
- |
$ -27 |
- |
Avenue Therapeutics, Inc. |
$ 18 |
- |
$ -12 |
- |
Avadel Pharmaceuticals Plc |
$ 294 |
- |
$ 0 |
- |
Aveo Pharmaceuticals Inc |
$ 398 |
$ 7 |
$ -66 |
- |
Aoxing Pharmaceutical Company, Inc. |
$ 9 |
$ 30 |
$ -1 |
- |
Axsome Therapeutics, Inc. |
$ 60 |
- |
$ 0 |
- |
Biodelivery Sciences International Inc |
$ 137 |
$ 62 |
$ 5 |
- |
Beigene, Ltd. |
$ 99,298 |
- |
$ -93 |
- |
Dnib Unwind, Inc. |
- |
- |
$ 0 |
- |
Biodel Inc |
- |
- |
$ 0 |
- |
Bellicum Pharmaceuticals, Inc. |
$ 250 |
$ 0 |
$ -92 |
- |
Bellerophon Therapeutics, Inc. |
$ 130 |
- |
$ -55 |
- |
Biomarin Pharmaceutical Inc |
$ 14,445 |
$ 1,314 |
$ -117 |
- |
Bristol Myers Squibb Co |
$ 83,726 |
$ 20,776 |
$ 975 |
25,000 |
Fitlife Brands, Inc. |
- |
- |
$ 0 |
- |
Blueprint Medicines Corp |
$ 3,285 |
$ 21 |
$ -148 |
- |
Biostar Pharmaceuticals, Inc. |
$ 7 |
- |
$ 1 |
- |
Biospecifics Technologies Corp |
$ 315 |
$ 27 |
$ 11 |
- |
Baxalta Inc |
- |
- |
$ 0 |
- |
Beyondspring Inc. |
$ 649 |
- |
$ -96 |
- |
Calithera Biosciences, Inc. |
$ 218 |
$ 26 |
$ -28 |
- |
Catabasis Pharmaceuticals Inc |
$ 39 |
- |
$ -27 |
- |
Cymabay Therapeutics, Inc. |
$ 594 |
- |
$ -28 |
- |
Cambrex Corp |
$ 1,848 |
$ 534 |
$ 102 |
- |
Columbia Laboratories Inc |
- |
- |
$ 0 |
- |
Carbylan Therapeutics, Inc. |
- |
- |
$ 0 |
- |
Chemocentryx, Inc. |
$ 579 |
$ 83 |
$ 18 |
- |
Celgene Corp |
$ 68,803 |
$ 12,998 |
$ 0 |
6,012 |
Chembio Diagnostics, Inc. |
$ 97 |
$ 24 |
$ -6 |
- |
Cempra, Inc. |
$ 122 |
$ 15 |
$ -77 |
- |
Cerulean Pharma Inc. |
- |
- |
$ -39 |
- |
Ceres Ventures, Inc. |
- |
- |
$ 0 |
- |
Contrafect Corp |
$ 128 |
- |
$ -4 |
- |
Chiasma, Inc |
$ 37 |
- |
$ -27 |
- |
China Pharma Holdings, Inc. |
- |
- |
$ 0 |
- |
Checkpoint Therapeutics, Inc. |
$ 94 |
- |
$ 0 |
- |
Colucid Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
Cellectar Biosciences, Inc. |
$ 19 |
- |
$ -14 |
- |
Clearside Biomedical, Inc. |
$ 289 |
$ 0 |
$ -59 |
- |
Celsion Corp |
$ 15 |
$ 1 |
$ -21 |
- |
Clovis Oncology, Inc. |
$ 2,511 |
$ 56 |
$ -346 |
- |
Chimerix Inc |
$ 240 |
$ 4 |
$ -71 |
- |
Conatus Pharmaceuticals Inc. |
$ 107 |
$ 35 |
$ -17 |
- |
Concert Pharmaceuticals, Inc. |
$ 922 |
$ 144 |
$ 0 |
- |
Coronado Biosciences Inc |
- |
- |
$ 0 |
- |
Global Green Inc. |
- |
- |
$ 0 |
- |
Collegium Pharmaceutical, Inc |
$ 802 |
$ 28 |
$ -75 |
- |
Corium International, Inc. |
$ 389 |
$ 34 |
$ -51 |
- |
Corcept Therapeutics Inc |
$ 2,255 |
$ 159 |
$ 129 |
- |
China Pharma Holdings, Inc. |
$ 13 |
$ 15 |
$ -21 |
- |
Cumberland Pharmaceuticals Inc |
$ 101 |
$ 41 |
$ -9 |
- |
Catalyst Pharmaceuticals, Inc. |
$ 230 |
- |
$ -18 |
- |
Corbus Pharmaceuticals Holdings, Inc. |
$ 359 |
$ 3 |
$ -32 |
- |
Cormedix Inc. |
$ 34 |
$ 0 |
$ -39 |
- |
Cardiome Pharma Corp |
- |
- |
$ 0 |
- |
Crispr Therapeutics Ag |
- |
- |
$ 0 |
- |
Corvus Pharmaceuticals, Inc. |
$ 218 |
- |
$ -56 |
- |
Cti Biopharma Corp |
$ 168 |
$ 25 |
$ -41 |
- |
Catalent, Inc. |
$ 5,732 |
$ 2,300 |
$ 70 |
- |
Contravir Pharmaceuticals, Inc. |
$ 9 |
- |
$ -8 |
- |
Cyclacel Pharmaceuticals, Inc. |
- |
- |
$ -7 |
- |
China Yct International Group, Inc. |
$ 20 |
$ 69 |
$ 13 |
- |
Cymabay Therapeutics, Inc. |
- |
- |
$ 0 |
- |
Cytokinetics Inc |
$ 384 |
$ 101 |
$ -21 |
- |
Dara Biosciences, Inc. |
- |
- |
$ 0 |
- |
Depomed Inc |
$ 422 |
$ 381 |
$ -102 |
- |
Dermira, Inc. |
$ 373 |
$ 5 |
$ -303 |
- |
Pronai Therapeutics Inc |
- |
- |
$ 0 |
- |
Dipexium Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
Dicerna Pharmaceuticals Inc |
$ 303 |
$ 2 |
$ -64 |
- |
Durect Corp |
$ 316 |
$ 49 |
$ -4 |
- |
Processa Pharmaceuticals, Inc. |
$ 327 |
- |
$ 0 |
- |
Dynavax Technologies Corp |
$ 1,108 |
$ 0 |
$ -95 |
- |
Eleven Biotherapeutics, Inc. |
$ 58 |
$ 1 |
$ -29 |
- |
Endocyte Inc |
$ 452 |
$ 0 |
$ -55 |
- |
Egalet Corp |
$ 27 |
$ 26 |
$ -69 |
- |
Eagle Pharmaceuticals, Inc. |
$ 2,593 |
$ 268 |
$ 97 |
- |
Elite Pharmaceuticals Inc |
$ 78 |
$ 8 |
$ 0 |
- |
Emisphere Technologies Inc |
$ 35 |
$ 1 |
$ -2 |
- |
Endo International Plc |
$ 1,230 |
$ 3,469 |
$ -2,035 |
- |
Enanta Pharmaceuticals Inc |
$ 1,743 |
$ 131 |
$ 34 |
- |
Epirus Biopharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
Epizyme, Inc. |
$ 1,100 |
- |
$ -134 |
- |
Esperion Therapeutics, Inc. |
$ 1,936 |
- |
$ -167 |
- |
Evoke Pharma Inc |
$ 37 |
- |
$ -12 |
- |
Eyegate Pharmaceuticals Inc |
$ 9 |
$ 0 |
$ -13 |
- |
Fortress Biotech, Inc. |
$ 191 |
$ 203 |
$ -104 |
- |
Fibrocell Science, Inc. |
$ 11 |
- |
$ -20 |
- |
Fibrogen Inc |
$ 3,823 |
$ 126 |
$ -126 |
- |
Flex Pharma, Inc. |
$ 91 |
$ 1 |
$ -34 |
- |
Flamel Technologies Sa |
- |
- |
$ 0 |
- |
Flexion Therapeutics Inc |
$ 906 |
- |
$ -137 |
- |
Fresenius Medical Care Ag & Co. Kgaa |
- |
- |
$ 0 |
- |
Antriabio, Inc. |
- |
- |
$ 0 |
- |
Amicus Therapeutics Inc |
$ 2,371 |
$ 37 |
$ -284 |
- |
Five Prime Therapeutics Inc |
$ 454 |
$ 40 |
$ -150 |
- |
Fitlife Brands, Inc. |
$ 3 |
$ 20 |
$ -2 |
- |
Futureworld Corp. |
- |
- |
$ 0 |
- |
Galectin Therapeutics Inc |
$ 133 |
- |
$ -16 |
- |
Globeimmune Inc |
- |
- |
$ 0 |
- |
Gb Sciences Inc |
$ 85 |
- |
$ -16 |
- |
Global Blood Therapeutics, Inc. |
$ 1,901 |
- |
$ -117 |
- |
Gemphire Therapeutics Inc. |
$ 62 |
- |
$ -33 |
- |
Geron Corp |
$ 604 |
- |
$ -33 |
- |
Guardion Health Sciences, Inc. |
- |
$ 0 |
$ -6 |
- |
Galmed Pharmaceuticals Ltd. |
$ 77 |
- |
$ 12 |
- |
Glycomimetics Inc |
$ 603 |
- |
$ -33 |
- |
Generex Biotechnology Corp |
$ 3 |
- |
$ -30 |
- |
Genspera Inc |
- |
- |
$ 0 |
- |
Genvec Inc |
$ 16 |
$ 0 |
$ -8 |
- |
Global Green Inc. |
- |
- |
$ 0 |
- |
Hutchison China Meditech Ltd |
$ 2,032 |
$ 241 |
$ -23 |
- |
Heron Therapeutics, Inc. |
$ 2,253 |
$ 32 |
$ -197 |
- |
HOSPIRA, INC. |
- |
- |
$ 0 |
- |
Heat Biologics, Inc. |
$ 39 |
$ 2 |
$ -12 |
- |
Horizon Pharma Plc |
$ 2,283 |
$ 1,158 |
$ -535 |
- |
Imagenetix Inc |
- |
- |
$ 0 |
- |
Ibio, Inc. |
$ 16 |
$ 0 |
$ -16 |
- |
Intercept Pharmaceuticals Inc |
$ 1,729 |
$ 131 |
$ -360 |
- |
Immune Design Corp. |
$ 146 |
$ 7 |
$ -52 |
- |
Immunogen Inc |
$ 1,283 |
$ 115 |
$ -96 |
- |
Imprimis Pharmaceuticals, Inc. |
$ 46 |
$ 27 |
$ -12 |
- |
Immune Pharmaceuticals Inc |
$ 6 |
- |
$ -25 |
- |
Immunocellular Therapeutics, Ltd. |
$ 9 |
- |
$ -18 |
- |
Innocoll Holdings Plc |
$ 69 |
- |
$ 0 |
- |
Insmed Inc |
$ 1,805 |
- |
$ -193 |
- |
Insite Vision Inc |
- |
- |
$ 0 |
- |
Insys Therapeutics, Inc. |
$ 511 |
$ 141 |
$ -228 |
- |
Intellipharmaceutics International Inc. |
$ 17 |
- |
$ 0 |
- |
Impax Laboratories Inc |
$ 1,435 |
$ 776 |
$ -469 |
- |
Ironwood Pharmaceuticals Inc |
$ 2,583 |
$ 292 |
$ -143 |
- |
Ionis Pharmaceuticals Inc |
- |
$ 508 |
$ -17 |
- |
Intra-cellular Therapies, Inc. |
$ 1,041 |
$ 0 |
$ -98 |
- |
Inotek Pharmaceuticals Corporation |
$ 82 |
- |
$ -38 |
- |
Jaguar Health, Inc. |
$ 15 |
$ 4 |
$ -22 |
- |
Jazz Pharmaceuticals Plc |
$ 9,665 |
$ 1,619 |
$ 488 |
- |
Johnson & Johnson |
$ 347,998 |
$ 76,450 |
$ 1,300 |
126,500 |
Juniper Pharmaceuticals Inc |
$ 98 |
$ 50 |
$ -1 |
- |
Kalobios Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
Kalvista Pharmaceuticals, Inc. |
$ 99 |
$ 3 |
$ -8 |
- |
Humanigen, Inc |
$ 33 |
- |
$ -22 |
- |
Kadmon Holdings, Inc. |
$ 330 |
$ 12 |
$ -80 |
- |
Keryx Biopharmaceuticals Inc |
$ 568 |
$ 61 |
$ -163 |
- |
Keyuan Petrochemicals, Inc. |
- |
- |
$ 0 |
- |
Kindred Biosciences, Inc. |
$ 270 |
- |
$ -31 |
- |
Kempharm, Inc |
$ 87 |
- |
$ -43 |
- |
Karyopharm Therapeutics Inc. |
$ 711 |
$ 0 |
$ -129 |
- |
China Shenghuo Pharmaceutical Holdings Inc |
- |
- |
$ 0 |
- |
Kura Oncology, Inc. |
$ 481 |
- |
$ -35 |
- |
Kythera Biopharmaceuticals Inc |
- |
- |
$ 0 |
- |
Lannett Co Inc |
$ 636 |
$ 640 |
$ 48 |
- |
Lifevantage Corp |
$ 55 |
$ 194 |
$ 1 |
- |
Ligand Pharmaceuticals Inc |
$ 4,031 |
$ 141 |
$ 13 |
- |
Lilly Eli & Co |
$ 82,491 |
$ 22,871 |
$ -204 |
39,135 |
Loxo Oncology, Inc. |
$ 3,994 |
- |
$ -149 |
- |
Lipocine Inc. |
$ 35 |
- |
$ -21 |
- |
Lexicon Pharmaceuticals, Inc. |
$ 885 |
$ 90 |
$ -129 |
- |
Merrimack Pharmaceuticals Inc |
$ 1,109 |
- |
$ 468 |
- |
Mabcure Inc. |
- |
- |
$ 0 |
- |
Moleculin Biotech, Inc. |
$ 39 |
- |
$ -10 |
- |
Seres Therapeutics, Inc. |
$ 313 |
$ 32 |
$ -89 |
- |
Medicines Co |
$ 2,184 |
$ 68 |
$ -708 |
- |
Medivation, Inc. |
- |
- |
$ 0 |
- |
Mei Pharma, Inc. |
$ 80 |
$ 6 |
$ -20 |
- |
Macrogenics Inc |
$ 870 |
$ 158 |
$ -20 |
- |
Mmrglobal, Inc. |
- |
- |
$ 0 |
- |
Mallinckrodt Plc |
$ 1,270 |
$ 3,222 |
$ 2,134 |
- |
Mannkind Corp |
$ 198 |
$ 12 |
$ -117 |
- |
Medicinova Inc |
$ 406 |
- |
$ -11 |
- |
Merck & Co., Inc. |
$ 158,630 |
$ 40,122 |
$ 2,418 |
70,000 |
Marinus Pharmaceuticals Inc |
$ 109 |
- |
$ -19 |
- |
Mirati Therapeutics, Inc. |
$ 786 |
- |
$ -70 |
- |
Mast Therapeutics, Inc. |
- |
- |
$ 0 |
- |
Mylan N.v. |
$ 22,367 |
$ 12,118 |
$ 1,233 |
25,000 |
Myos Rens Technology Inc. |
$ 8 |
$ 1 |
$ -4 |
- |
Myovant Sciences Ltd. |
$ 1,258 |
- |
$ 0 |
- |
Natures Sunshine Products Inc |
$ 182 |
$ 342 |
$ -14 |
- |
Nabriva Therapeutics Plc |
$ 320 |
$ 5 |
$ -74 |
- |
Novabay Pharmaceuticals, Inc. |
$ 51 |
$ 18 |
$ -7 |
- |
Neos Therapeutics, Inc. |
$ 237 |
$ 25 |
$ -66 |
- |
Neothetics, Inc. |
$ 27 |
- |
$ -10 |
- |
Minerva Neurosciences, Inc. |
$ 279 |
- |
$ -32 |
- |
China Nuokang Bio-pharmaceutical Inc. |
- |
- |
$ 0 |
- |
Nektar Therapeutics |
$ 27,138 |
$ 308 |
$ -97 |
- |
Newlink Genetics Corp |
$ 165 |
$ 29 |
$ -72 |
- |
Novan, Inc. |
$ 50 |
$ 2 |
$ -37 |
- |
Inergetics Inc |
- |
- |
$ 0 |
- |
Nephrogenex, Inc. |
- |
- |
$ 0 |
- |
Inspyr Therapeutics, Inc. |
$ 0 |
- |
$ 0 |
- |
Neurotrope, Inc. |
$ 69 |
- |
$ -13 |
- |
Nexvet Biopharma Plc |
$ 79 |
- |
$ -20 |
- |
Novelion Therapeutics Inc. |
- |
- |
$ 0 |
- |
Nivalis Therapeutics, Inc. |
$ 38 |
- |
$ -18 |
- |
Novelos Therapeutics, Inc. |
- |
- |
$ 0 |
- |
Northwest Biotherapeutics Inc |
$ 61 |
$ 0 |
$ -74 |
- |
Northwest Biotherapeutics Inc |
- |
- |
$ 0 |
- |
Ocera Therapeutics, Inc. |
$ 47 |
- |
$ -26 |
- |
Ocular Therapeutix, Inc. |
$ 190 |
$ 2 |
$ -63 |
- |
Oragenics Inc |
$ 76 |
- |
$ -7 |
- |
Ohr Pharmaceutical Inc |
$ 13 |
- |
$ -21 |
- |
Oncomed Pharmaceuticals Inc |
$ 120 |
$ 38 |
$ -39 |
- |
Omeros Corp |
$ 674 |
$ 65 |
$ -53 |
- |
Oncosec Medical Inc |
$ 55 |
- |
$ -29 |
- |
Onconova Therapeutics, Inc. |
$ 6 |
$ 1 |
$ -24 |
- |
Ophthotech Corp. |
$ 96 |
$ 215 |
$ 114 |
- |
Opko Health, Inc. |
$ 3,446 |
$ 1,068 |
$ -309 |
- |
Acer Therapeutics Inc. |
$ 3 |
- |
$ -7 |
- |
Orexigen Therapeutics, Inc. |
$ 3 |
$ 75 |
$ -145 |
- |
Oramed Pharmaceuticals Inc. |
$ 107 |
$ 5 |
$ 15 |
- |
Oragenics Inc |
- |
- |
$ 0 |
- |
Bioblast Pharma Ltd. |
- |
- |
$ 0 |
- |
Otonomy, Inc. |
$ 114 |
$ 1 |
$ -90 |
- |
Ovascience, Inc. |
$ 31 |
$ 0 |
$ -51 |
- |
Phibro Animal Health Corp |
$ 1,776 |
$ 784 |
$ 62 |
- |
Prestige Brands Holdings, Inc. |
$ 1,620 |
$ 1,026 |
$ 497 |
- |
Puma Biotechnology, Inc. |
$ 2,299 |
- |
$ -292 |
- |
Pacira Pharmaceuticals, Inc. |
$ 1,462 |
$ 287 |
$ -43 |
- |
Aratana Therapeutics, Inc. |
$ 216 |
$ 26 |
$ -48 |
- |
Pfizer Inc. |
$ 210,366 |
$ 53,168 |
$ 19,195 |
78,300 |
Pfenex Inc. |
$ 129 |
- |
$ -71 |
- |
Progenics Pharmaceuticals Inc |
$ 493 |
$ 12 |
$ -51 |
- |
Pharmathene, Inc |
- |
$ 5 |
$ 114 |
- |
Peak Pharmaceuticals, Inc. |
$ 7 |
- |
$ 0 |
- |
Pozen Inc |
- |
- |
$ 0 |
- |
Propanc Biopharma, Inc. |
- |
- |
$ -9 |
- |
Avid Bioservices, Inc. |
$ 191 |
$ 65 |
$ -30 |
- |
Perrigo Co Plc |
$ 11,562 |
$ 4,946 |
$ 120 |
- |
Prophase Labs, Inc. |
$ 36 |
$ 10 |
$ 42 |
- |
Prothena Corp Plc |
$ 1,418 |
$ 28 |
$ -153 |
- |
Paratek Pharmaceuticals, Inc. |
$ 308 |
$ 13 |
$ -89 |
- |
Protect Pharmaceutical Corp |
$ 1 |
- |
$ 0 |
- |
Protalex Inc |
$ 12 |
- |
$ -5 |
- |
Proto Script Pharmaceutical Corp |
$ 1 |
- |
$ 0 |
- |
Ptc Therapeutics, Inc. |
$ 1,089 |
$ 194 |
$ -79 |
- |
Patheon N.v. |
$ 5,116 |
- |
$ 0 |
- |
Pain Therapeutics Inc |
$ 358 |
- |
$ -11 |
- |
Portola Pharmaceuticals Inc |
$ 2,191 |
$ 27 |
$ -249 |
- |
Palatin Technologies Inc |
$ 272 |
$ 82 |
$ 23 |
- |
Pernix Therapeutics Holdings, Inc. |
$ 39 |
$ 146 |
$ -71 |
- |
Provectus Biopharmaceuticals, Inc. |
$ 29 |
- |
$ -14 |
- |
Phaserx, Inc. |
$ 3 |
- |
$ 4 |
- |
Novelion Therapeutics Inc. |
- |
- |
$ 0 |
- |
Uniqure N.v. |
$ 1,008 |
$ 13 |
$ -79 |
- |
Ultragenyx Pharmaceutical Inc. |
$ 2,305 |
- |
$ -292 |
- |
Ra Pharmaceuticals, Inc. |
$ 141 |
- |
$ 0 |
- |
Rock Creek Pharmaceuticals, Inc. |
- |
- |
$ 0 |
5 |
Radius Health, Inc. |
$ 1,484 |
- |
$ -261 |
- |
Regeneron Pharmaceuticals Inc |
$ 36,310 |
$ 5,872 |
$ 1,199 |
- |
Reliv International Inc |
$ 9 |
$ 42 |
$ -1 |
- |
Recro Pharma, Inc. |
$ 220 |
$ 72 |
$ -50 |
- |
Reata Pharmaceuticals Inc |
$ 624 |
$ 48 |
$ -48 |
- |
Regulus Therapeutics Inc. |
$ 68 |
$ 0 |
$ -72 |
- |
Rigel Pharmaceuticals Inc |
$ 555 |
$ 19 |
$ -78 |
- |
Relypsa Inc |
- |
- |
$ 0 |
- |
Rexahn Pharmaceuticals, Inc. |
$ 47 |
- |
$ -25 |
- |
Rosetta Genomics Ltd. |
$ 1 |
$ 21 |
$ 54 |
- |
Raptor Pharmaceutical Corp |
- |
- |
$ 0 |
- |
Retrophin, Inc. |
$ 1,103 |
$ 158 |
$ -31 |
- |
Ritter Pharmaceuticals Inc |
$ 149 |
- |
$ -8 |
- |
Revance Therapeutics, Inc. |
$ 965 |
$ 0 |
$ -121 |
- |
Ignyta, Inc. |
$ 1,516 |
- |
$ -120 |
- |
Rxi Pharmaceuticals Corp |
$ 6 |
- |
$ -12 |
- |
Sage Therapeutics, Inc. |
$ 5,546 |
- |
$ -257 |
- |
Spring Bank Pharmaceuticals, Inc. |
$ 185 |
- |
$ -28 |
- |
Sciclone Pharmaceuticals Inc |
$ 594 |
$ 172 |
$ 43 |
- |
Sucampo Pharmaceuticals, Inc. |
$ 1,171 |
$ 250 |
$ -151 |
- |
Scynexis Inc |
$ 38 |
$ 0 |
$ -25 |
- |
Sagent Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
Signpath Pharma, Inc. |
- |
- |
$ 0 |
- |
Synergy Pharmaceuticals, Inc. |
$ 493 |
- |
$ -244 |
- |
Shire Plc |
- |
$ 15,161 |
$ 4,272 |
- |
Shire Plc |
- |
- |
$ 0 |
- |
Siga Technologies Inc |
- |
- |
$ 0 |
- |
Siga Technologies Inc |
- |
$ 6 |
$ -32 |
- |
Sunset Island Group, Inc |
- |
- |
$ 0 |
- |
Skystar Bio-pharmaceutical Co |
- |
- |
$ 0 |
- |
Sibannac, Inc. |
$ 2 |
$ 0 |
$ 0 |
- |
Sunesis Pharmaceuticals Inc |
$ 90 |
$ 3 |
$ -35 |
- |
Madrigal Pharmaceuticals, Inc. |
- |
- |
$ -31 |
- |
Sophiris Bio Inc. |
$ 66 |
$ 0 |
$ -9 |
- |
Spectrum Pharmaceuticals Inc |
$ 1,845 |
$ 128 |
$ -91 |
- |
Sarepta Therapeutics, Inc. |
$ 5,113 |
$ 155 |
$ -51 |
- |
Sierra Oncology, Inc. |
$ 99 |
- |
$ -42 |
- |
Steadymed Ltd. |
$ 103 |
$ 1 |
$ 16 |
- |
Stemline Therapeutics Inc |
$ 407 |
$ 1 |
$ -68 |
- |
Supernus Pharmaceuticals Inc |
$ 2,599 |
$ 302 |
$ 57 |
- |
Sinovac Biotech Ltd |
- |
- |
$ 0 |
- |
Savara Inc. |
$ 261 |
- |
$ -30 |
- |
Growblox Sciences, Inc. |
- |
- |
$ 0 |
- |
Synthetic Biologics, Inc. |
$ 44 |
- |
$ -15 |
- |
Syros Pharmaceuticals, Inc. |
$ 331 |
- |
$ -54 |
- |
Taro Pharmaceutical Industries Ltd |
- |
- |
$ 0 |
- |
Theravance Biopharma, Inc. |
$ 1,295 |
$ 2 |
$ -319 |
- |
Teva Pharmaceutical Industries Ltd |
$ 20,582 |
$ 23,144 |
$ -11,653 |
- |
Threshold Pharmaceuticals Inc |
$ 39 |
- |
$ -13 |
- |
Innoviva, Inc. |
- |
$ 217 |
$ 134 |
- |
Tokai Pharmaceuticals Inc |
- |
- |
$ -30 |
- |
Tetralogic Pharmaceuticals Corp |
- |
- |
$ 0 |
- |
Tonix Pharmaceuticals Holding Corp. |
$ 25 |
- |
$ -21 |
- |
Tocagen Inc |
$ 206 |
- |
$ 0 |
- |
Tianyin Pharmaceutical Co., Inc. |
- |
- |
$ 0 |
- |
Tapimmune Inc. |
$ 31 |
- |
$ -11 |
- |
Trevena Inc |
$ 108 |
- |
$ -72 |
- |
Transcept Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
Tesaro, Inc. |
$ 2,807 |
$ 223 |
$ -496 |
- |
Titan Pharmaceuticals Inc |
$ 20 |
$ 0 |
$ -14 |
- |
Tetraphase Pharmaceuticals Inc |
$ 167 |
$ 10 |
$ -115 |
- |
Therapeuticsmd, Inc. |
$ 1,216 |
$ 17 |
$ -77 |
- |
Shineco, Inc. |
$ 33 |
$ 16 |
$ 3 |
- |
United Therapeutics Corp |
$ 5,098 |
$ 1,725 |
$ 418 |
- |
Vaccinogen Inc |
- |
- |
$ 0 |
- |
Viking Therapeutics, Inc. |
$ 165 |
- |
$ -20 |
- |
Vanda Pharmaceuticals Inc. |
$ 667 |
$ 165 |
$ -16 |
- |
Vertex Pharmaceuticals Inc |
$ 41,482 |
$ 2,489 |
$ 92 |
- |
Valeant Pharmaceuticals International, Inc. |
$ 6,087 |
$ 8,724 |
$ 2,404 |
- |
Versartis, Inc. |
$ 54 |
- |
$ -85 |
- |
Verastem, Inc. |
$ 177 |
- |
$ -68 |
- |
Vitae Pharmaceuticals, Inc |
- |
- |
$ 0 |
- |
Vital Therapies Inc |
$ 239 |
- |
$ -52 |
- |
Vtv Therapeutics Inc. |
$ 20 |
$ 0 |
$ -55 |
- |
Vivus Inc |
$ 41 |
$ 65 |
$ -31 |
- |
World Health Energy Holdings, Inc. |
$ 9 |
- |
$ 0 |
- |
Wuxi Pharmatech (cayman) Inc. |
- |
- |
$ 0 |
- |
Xbiotech Inc. |
$ 172 |
- |
$ -33 |
- |
Xenon Pharmaceuticals Inc. |
$ 91 |
$ 0 |
$ -31 |
- |
Xencor Inc |
$ 1,404 |
$ 36 |
$ -49 |
- |
Xenoport Inc |
- |
- |
$ 0 |
- |
Xoma Corp |
$ 216 |
$ 53 |
$ 6 |
- |
Zafgen, Inc. |
$ 189 |
- |
$ -48 |
- |
Zogenix, Inc. |
$ 1,393 |
$ 27 |
$ -127 |
- |
Zosano Pharma Corp |
$ 166 |
- |
$ -29 |
- |
Zs Pharma, Inc. |
- |
- |
$ 0 |
- |
Zoetis Inc. |
$ 41,951 |
$ 5,307 |
$ 862 |
- |
Zynerba Pharmaceuticals, Inc. |
$ 142 |
- |
$ -32 |
- |
Ovid Therapeutics Inc. |
$ 248 |
- |
$ -65 |
- |
Shuttle Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
Tyme Technologies, Inc. |
$ 198 |
- |
$ 0 |
- |
Plx Pharma Inc. |
$ 37 |
- |
$ 0 |
- |
Athenex, Inc. |
$ 931 |
- |
$ 0 |
- |
Iaso Biomed, Inc. |
- |
- |
$ 0 |
- |
Innovation Pharmaceuticals Inc. |
$ 62 |
- |
$ 0 |
- |
Luckycom Pharmaceuticals Inc. |
$ 64 |
- |
$ 0 |
- |
Nuo Therapeutics, Inc. |
$ 4 |
- |
$ 0 |
- |
Synlogic, Inc. |
$ 155 |
- |
$ 0 |
- |
Molecular Templates, Inc. |
$ 140 |
- |
$ 0 |
- |
Alpine Immune Sciences, Inc. |
$ 70 |
- |
$ 0 |
- |
Apellis Pharmaceuticals, Inc. |
$ 813 |
- |
$ 0 |
- |
Major Pharmaceutical Preparations Industry |
$ 1,612,473 |
$ 367,373 |
$ 7,775 |
449,225 |
Earnings |
|
Earnings |
|
Earnings |
|
Earnings Outlook increase
Looking into earnings estimates within the Major Pharmaceutical Preparations Industry in the current quarter, 33.33 % of companies, who provide earning guidance within Major Pharmaceutical Preparations Industry have increased their earnings outlook for the current fiscal year. But this falls short, as more corporations cut their earnings estimates. |
Earnings Guidance unchanged
In the same quarter 22.22 % of companies, who provided earning outlook within Major Pharmaceutical Preparations Industry, have reiterated their earnings per share outlook for the current fiscal year unchanged. |
Earnings Estimates
decrease
Pessimism dominates within Major Pharmaceutical Preparations Industry, as most of the businesses cut their earnings guidance, staggering 44.44 % have revised down earnings outlook. Overall earnings expectations for the Major Pharmaceutical Preparations Industry were cut by %, to the annual earnings expectation of %. |
|
Expected
Eps Growth |
|
|
Eps
Expectation Revision |
|
|
% Industry
Expected EPS Growth |
Total Ranking # Within Sector # |
|
|
% Industry
Earnings Outlook Revision |
Total Ranking # Within Sector # |
|
|
Revenue |
|
Revenue |
|
Revenue |
Sales Forecast increase
In the current quarter 33.33 % of companies, who have issued revenue expectation within Major Pharmaceutical Preparations Industry, have expressed their optimism, by increasing revenue outlook for the current fiscal year. |
Sales Expectations unchanged
As even more corporations reiterate their sales projections, 66.67 % of businesses within Major Pharmaceutical Preparations Industry, while corporate executives do not expect any change of economic environment. |
Sales Outlook decrease
In Major Pharmaceutical Preparations Industry, there were no sales guidance decreases |
|
Expected
Revenue Growth |
|
|
Revenue
Expectation Revision |
|
|
% Industry
Expected Revenue Growth |
Total Ranking # Within Sector # |
|
|
% Industry
Revenue Outlook Revision |
Total Ranking # Within Sector # |
|
|
|
Cardiovascular Segment |
Revenues |
Income |
-3.79% |
5.25% |
53.25% |
648.7% |
Y/Y |
Q/Q |
Y/Y |
Q/Q |
Neuroscience Segment |
Revenues |
Income |
- |
- |
- |
- |
Y/Y |
Q/Q |
Y/Y |
Q/Q |
Anti-Infective Segment |
Revenues |
Income |
14.75% |
-7.45% |
23.14% |
-12.12% |
Y/Y |
Q/Q |
Y/Y |
Q/Q |
Respiratory Segment |
Revenues |
Income |
-3.79% |
5.25% |
53.25% |
648.7% |
Y/Y |
Q/Q |
Y/Y |
Q/Q |
Arthritis & Pain Segment |
Revenues |
Income |
24.3% |
7.73% |
- |
- |
Y/Y |
Q/Q |
Y/Y |
Q/Q |
Urology Segment |
Revenues |
Income |
-3.79% |
5.25% |
53.25% |
648.7% |
Y/Y |
Q/Q |
Y/Y |
Q/Q |
Oncology Segment |
Revenues |
Income |
9.97% |
1.68% |
- |
- |
Y/Y |
Q/Q |
Y/Y |
Q/Q |
Endocrine Segment |
Revenues |
Income |
-34.8% |
-30.47% |
- |
- |
Y/Y |
Q/Q |
Y/Y |
Q/Q |
|
|